Overview

Lactoferrin Use in ICU Patients

Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-29
Target enrollment:
Participant gender:
Summary
Introduction: Lactoferrin has several uses due to its effects. It has anti-inflammatory, antioxidant, immunomodulatory, antibacterial, antifungal, and antiviral effects. Its safety is proven by food and drug administration. Aims: The objective is to study the effect of lactoferrin on improving clinical outcomes in ICU patients, and also to evaluate its safety. Patients and populations: A sample of 660 patients (330 patients in both groups A, and B) who will be admitted to ICU departments in Mansoura university hospital will be used to represent the population in ICU. Methods: A sample of 660 participants was randomized 1:1 into two groups (group A (330 patients), and group B (330 patients)). This study is a single blind, randomized controlled clinical trial. Randomization was performed by independent clinical pharmacists working in hospital ICU departments.
Phase:
PHASE4
Details
Lead Sponsor:
Mansoura University Hospital
Treatments:
Dexamethasone
Lactoferrin